Skip to main content
Premium Trial:

Request an Annual Quote

Genera's Upcoming IPO Oversubscribed

NEW YORK (GenomeWeb News) – Australian molecular diagnostics developer Genera Biosystems said today that its upcoming initial public offering has closed oversubscribed, with demand for shares outweighing the number of shares offered.
 
The company expects its stock will begin trading on the Australian Stock Exchange under the ticker symbol GBI during the first week of June. Genera said it expects its market capitalization to be around AU $25 million ($24.1 million) when it begins trading.
 
Genera’s first product is the PapType, a test for human papillomavirus, and it also has another test for other sexually transmitted diseases in advanced pre-clinical development.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.